Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2010 1
2011 1
2014 3
2015 2
2016 4
2017 2
2018 3
2019 3
2020 4
2021 4
2022 6
2023 2
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.
Subramanian A, Su S, Flerlage J, Alig S, Younes S, Marks LJ, Pinnix C, Vega F, Steiner R, Kumar P, Mocikova H, Sykorova A, Prochazka V, Milito C, Allen P, Paulino D, Ramsay A, Flerlage T, Palese M, West R, Zhu C, Noordenbos T, Schroers-Martin J, Zhao S, Park NJ, Kalbasi A, Moding EJ, Newman AM, Advani RH, Hoppe RT, Diehn M, Natkunam Y, Alizadeh AA, Binkley MS. Subramanian A, et al. Among authors: sykorova a. Nat Commun. 2025 Sep 26;16(1):8473. doi: 10.1038/s41467-025-63339-9. Nat Commun. 2025. PMID: 41006203 Free PMC article.
Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration.
Sýkorová A, Folber F, Polgárová K, Móciková H, Ďuraš J, Steinerová K, Obr A, Heindorfer A, Ladická M, Lukáčová Ľ, Čellárová E, Plameňová I, Belada D, Janíková A, Trněný M, Jančárková T, Procházka V, Vranovský A, Králiková M, Vydra J, Smolej L, Drgoňa Ľ, Sedmina M, Čermáková E, Pytlík R. Sýkorová A, et al. Cancer Med. 2024 Sep;13(17):e70138. doi: 10.1002/cam4.70138. Cancer Med. 2024. PMID: 39248284 Free PMC article.
Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study.
Kreslová M, Jehlička P, Sýkorová A, Rajdl D, Klásková E, Prokop P, Kaprálová S, Pavlíček J, Kaslová R, Palátová A, Mohylová V, Sýkora J. Kreslová M, et al. Among authors: sykorova a. Biomedicines. 2022 Nov 17;10(11):2956. doi: 10.3390/biomedicines10112956. Biomedicines. 2022. PMID: 36428524 Free PMC article.
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.
Hutchings M, Radford J, Ansell SM, Illés Á, Sureda A, Connors JM, Sýkorová A, Shibayama H, Abramson JS, Chua NS, Friedberg JW, Kořen J, LaCasce AS, Molina L, Engley G, Fenton K, Jolin H, Liu R, Gautam A, Gallamini A. Hutchings M, et al. Among authors: sykorova a. Hematol Oncol. 2021 Apr;39(2):185-195. doi: 10.1002/hon.2838. Epub 2021 Feb 16. Hematol Oncol. 2021. PMID: 33462822 Free PMC article.
37 results